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Abstract
BACKGROUND: Recently, the role of neutrophil extracellular traps (NETs) in oncopathology, including colorectal cancer 
(CRC), has become a subject of discussion. Literature review showed that in CRC, there are separate experimental and 
clinical studies devoted to assess the ability of neutrophils to form NET. A methodological approach, common to these 
studies, was that the ability of blood neutrophils in patients with CRC to form NET was evaluated in vitro. 
AIM: We undertook a study of the NETs presence in the tumor tissues, on the periphery of the tumor, and in healthy 
tissues with CRC at different stages and different types of therapy.
METHODS: The study was carried out in the framework of the scientific and technical program “Personalized 
approach to the management of number of significant diseases” developed by the Non-commercial Joint-Stock 
Company “Karaganda Medical University,” funded by the Ministry of Education and Science of the Republic of 
Kazakhstan.
RESULTS: Patients with CRC II and III stages are more likely to have NET in the center, on the periphery of the tumor 
and in healthy tissues adjacent to the tumor than in patients with CRC of Stage I. It was also found that radiation 
therapy as a pre-operative preparation contributed to an increase in the number of NET in the center of the tumor in 
patients with Stage I rectal cancer. 
CONCLUSION: Thus, our data revealed an increase in NET in the center and periphery of CRC, and an increase in 
their number after pre-operative radiation therapy was shown. The next stage of our study will be devoted to study 
the structural features of NET and their interaction with other effector cells and tumor cells.
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Introduction
Colorectal cancer (CRC) is one of the most 
common malignant tumors in the world, the incidence 
is growing in both developed and developing countries. 
It takes the third place in the general structure of 
malignant tumors and is the fourth leading cause of 
cancer mortality worldwide [1].
In Kazakhstan, in recent years, there has been 
an increase in the incidence of CRC. The intensive 
indicator of CRC incidence in 2018 amounted to 9.1% 
per 100 thousand people (2017 – 9.4%) with an increase 
rate of 3.7%, which in absolute numbers are 1667 
new cases per year. The intensive indicator of CRC 
incidence in 2018 amounted to 8.4% per 100 thousand 
people (2017 – 8.1%) with a growth rate 4.6%, which 
in absolute numbers are 1551 new cases per year [2].
CRC takes the fifth place in cancer mortality rate 
in Kazakhstan, after lung cancer, stomach cancer, breast 
cancer, and pancreatic cancer (5.3%). Rectal cancer 
takes the seventh place in cancer mortality rate (4.8%) [2].
The incidence and urgency problem of CRC 
requires an in-depth study of the molecular-cellular 
changes accompanying with disease development and 
treatment.
The leading role in the immune system response 
is played by neutrophils, which have high cytotoxic 
potential and intertissue mobility. The cytotoxic potential 
of neutrophils is realized through various mechanisms, 
including through the formation of neutrophil extracellular 
traps (NETs). Different mechanisms of NET formation 
have been described: Suicidal NETosis and vital 
(intravital) NETosis. Suicidal NETosis is induced by 
various chemical factors, the interaction of which with 
receptors on the neutrophil membrane triggers a cascade 
of intracellular transformations resulting in the destruction 
of granules, chromatin decondensation in the nucleus, 
nuclear membrane decay, attachment of granular 
proteins to nuclear fibrils, rupture of the cell membrane, 
 Muravlyova et al. Quantitative Characteristics of Neutrophil Extracellular Traps in Tumor Tissues in Colorectal Cancer
Open Access Maced J Med Sci. 2020 Nov 14; 8(B):1152-1156. 1153
and the release of a complex of DNA and histones into 
the environment with the formation of a network. Granular 
proteins are represented by myeloperoxidase, elastase, 
lysozyme C, etc., which determine the efficiency of 
pathogenic microorganisms degradation [3].
Vital NETosis is induced by bacterial factors; 
it is not accompanied by cell lysis; the nucleus DNA is 
released using vesicles [4].
Recently, the role of NET in oncopathology, 
including CRC, has become a subject of discussion. 
Literature review showed that in CRC, there are separate 
experimental and clinical studies devoted to assess the 
ability of neutrophils to form NET. A methodological 
approach, common to these studies, was that the ability 
of blood neutrophils in patients with CRC to form NET 
was evaluated in vitro. After isolation, neutrophils were 
primed with various stimuli and their ability to form NET 
relative to those of the control group was evaluated. 
Based on these studies, it was concluded that an 
increase in the number of neutrophils forming NET 
contributes to increased metastasis of CRC [5], [6].
Literature review showed different opinions on 
the role of NET in CRC. In this regard, we undertook a 
study of the NETs presence in the tumor tissues, on the 
periphery of the tumor, and in healthy tissues with CRC 
at different stages and different types of therapy.
Materials and Methods
Study design
This was a clinical, prospective study.
Study condition
The study was carried out in the framework 
of the scientific and technical program STP O.0821 
“Personified Approach to the Management of a Number 
of Significant Diseases” funded by the Ministry of 
Education and Science of the Republic of Kazakhstan 
(IRN BR05236771).
Sample size justification and recruitment 
method
The study involved 168 patients with an 
established diagnosis of CRC. These are all patients 
treated at the Regional Oncological Dispensary of 
Karaganda for 2018–2019. All patients were divided into 
seven age categories: Up to 30 years old, 31–40 years 
old, 41–50 years old, 51–60 years old, 61–70 years old, 
71–80 years old, and over 80 years old. Inclusion in the 
study meant familiarizing the patient with the essence 
of the study and signing an informed consent.
Ethical approval
The study was approved by the Bioethics 
Committee of Karaganda Medical University.
The clinical diagnosis was established 
according to ICD 10 [7]; for cancer stages, classification 
of the TNM classification developed by the International 
Cancer Union, 2019 version, was used [8].
Study description
On admission to the hospital, all examined 
patients underwent a general clinical examination at the 
outpatient stage. Morphological verification of tumors 
was carried out in the cytological and morphological 
laboratories of the Regional Clinical Oncology Center, 
Karaganda. All patients have histological verification, 
mainly, adenocarcinoma with localization of the tumor 
in the colon and rectosigmoid and ampullary sections of 
the rectum, with localization of the tumor in the perineal 
region – squamous cell carcinoma.
After the diagnosis verification and a full 
examination, all patients underwent surgical treatment.
Out of 168 patients with colon and rectum 
cancer, 82 patients were examined to NETs.
The number of extracellular DNA networks in 
tumor imprint smears was estimated during the operation. 
A imprint smear was taken from the center of the tumor 
dissected in the sector, on the periphery of the tumor and 
in healthy tissues on glass slides and stained according 
to azure-eosin according to the May-Grunwald method 
[9], with a light microscope at 1400 times magnification 
with extracellular DNA counting by the method described 
by Dolgushin et al. [9], [10], [11]. Counting was carried 
out on 10 fields of view. NET photographs were obtained 
using the ToupView 3.7 program.
For the statistical processing of the obtained 
results, the mathematical statistics procedures 
implemented in the STATISTICA 10.0 and EXСEL 
applications were used. Preliminarily obtained results 
were checked for normal distribution. Results are 
presented medians and quartiles, the difference 
between the indicators in the compared groups was 
calculated according to Mann–Whitney.
Patients’ characteristics: Out of 82 patients, 
there were 30 women and 52 men aged 37–85, the 
average age of the patients was 65.5 ± 8.4. There were 14 
(17.0%) patients with the first stage of cancer, 49 (59.8%) 
people with the second stage, and 19 (23.2%) patients 
with the third stage of cancer. CRC was diagnosed in 43 
(52.4%) patients, of which 33 (76.7%) patients received 
a neoadjuvant course of radiation therapy. In terms of 
combined treatment, at the first stage, they conducted 
a neoadjuvant course of remote gamma therapy on the 
ROCUS AM apparatus in the rectal region, pararectal 
tissue, and regional lymph nodes (single boost dose of 
20 Gy and total boost dose of 40 Gy).
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Colon cancer was diagnosed in 39 (47.6%) 
patients, of which 19 (48.7%) patients were diagnosed 
with sigmoid colon cancer. All patients underwent 
surgical treatment.
All patients were divided into two groups. The 
first group included patients who had undergone surgical 
treatment immediately after the diagnosis of CRC. This 
group included 10 patients with Stage I CRC, 28 patients 
with Stage II CRC, and 11 patients with Stage III CRC. 
The second group included patients who had received a 
neoadjuvant course of radiation therapy.
This group included 4 patients with Stage I 
rectal cancer, 21 patients with Stage II rectal cancer, 
and 8 patients with Stage III rectal cancer.
Results
The research results are presented in Table 1.
Table 1: Quantitative characteristics of tissue NETs in patients 
with CRC (median/25–57% CI)
Cancer prevalence Colorectal 
cancer patients 
after surgery
Colorectal cancer patients 
after neoadjuvant radiation 
therapy and surgery
р ≤ 0.05
I stage
At the center of the tumor 1.5 (0; 15) 7.5 (1; 21,5) р ≥ 0.05
At the periphery of the tumor 11 (0; 24) 8 (3;18) р ≤ 0.05
In healthy tissues 0 (0; 0) 2,5 (0;9)
II stage
At the center of the tumor 8 (0;16) 10 (5; 15) р ≥ 0.05
At the periphery of the tumor 11 (4; 22) 11 (4; 25) р ≥ 0.05
In healthy tissues 0 (0;3) 0 (0; 0)
III stage
At the center of the tumor 5 (0;11) 12 (0; 30) р ≥ 0.05
At the periphery of the tumor 7.5 (0,5;13) 8 (1;19) р ≥ 0.05
In healthy tissues 0 (0;9.5) 0 (0; 25)
NET: Neutrophil extracellular trap, CRC: Colorectal cancer.
As a study result, it was found that at patients 
with Stage I CRC included in Group 1, after surgery, 
the number of NET varied. Hence, in the center of the 
tumor, NET was found in 50% of patients with CRC; 
the median value was – 1.5 (0; 15). At the periphery 
of the tumor, NET was found in 70% of patients in this 
group; the median value was 11 (0; 24). In healthy 
tissue adjacent to the tumor, NET was found in 10% of 
patients; the median value was 0 (0; 0).
In patients with Stage II CRC, included in 
Group I, after surgical treatment, NET in the center of the 
tumor was found in 72% of patients; the median value 
was 8 (0; 16) (Figure 1). At the periphery of the tumor, 
NET was found in 89% of patients in this group, the 
median value was 11 (4; 22). In healthy tissue adjacent 
to the tumor, NET was found in 25% of patients; the 
median value was 0 (0; 3).
In patients with Stage III CRC, included in 
Group 1, after surgical treatment, NET in the center of 
the tumor was found in 63% of patients; the median 
value was 5 (0; 11). At the periphery of the tumor, 
NET was found in 72% of patients in this group, the 
median value was 7.5 (0.5; 13) (Figure 2). In healthy 
tissue adjacent to the tumor, NET was found in 27% of 
patients; the median value was 0 (0; 9.5).
Figure 1: Neutrophil extracellular traps in the tumor center of a patient 
with colorectal cancer (May-Grunwald azure-eosin staining, 1400×)
Neoadjuvant preparation, then surgery, NET in 
the center of the tumor was found in 75% of patients; 
the median value was 7.5 (1; 21.5). At the periphery 
of the tumor, NET was found in 100% of patients in 
this group; the median value was 8 (3; 18). In healthy 
tissues adjacent to the tumor, GNI was found in 50% of 
patients in this group; the median value was 2.5 (0; 9).
Figure 2: Neutrophil extracellular traps in the tumor periphery of a 
patient with colorectal cancer (May-Grunwald staining with azure-
eosin, 1400×)
In patients with Stage II CRC who received 
radiation therapy as a neoadjuvant preparation, then 
surgery, NET in the center of the tumor was found 
in 81% of patients, the median value was 10 (5; 15) 
(Figure 3). At the periphery of the tumor, NET was found 
in 76% of patients, the median value was 11 (4; 25). In 
normal tissue, NET was found in 24% of the examined 
patients, the median value was 0 (0; 0).
In patients with Stage III CRC who received 
radiation therapy as a neoadjuvant preparation, then 
surgery, NET in the center of the tumor was found 
in 75% of patients, the median value was 12 (0; 30) 
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(Figure 4). At the periphery of the tumor, NET was found 
in 87.5% of the examined patients; the median value 
was 8 (1; 19). In normal tissue, NET was found in 50% 
of the examined patients; the median value is 0 (0; 25).
Figure 3: Neutrophil extracellular traps in the tumor center of a patient 
with colorectal cancer after radiation therapy (May-Grunwald azure-
eosin staining, 1400×)
Discussion
As a study result, it was found that in patients 
with CRC in the center of the tumor and on the periphery 
of the tumor, NET is detected. Our data supplement the 
results of Arelaki et al. [12], which showed the presence 
of NET in tumor sections of CRC. We did not observe 
a decrease in the amount of NET from the center to 
the periphery of the tumor. As our studies showed, the 
amount of NET in the center of the tumor and on the 
periphery was comparable.
Figure 4: Neutrophil extracellular traps in the tumor periphery of a 
patient with colorectal cancer after radiation therapy (May-Grunwald 
azure-eosin staining, 1400×)
Patients with CRC of Stages II and III are more 
likely to have NET in the center, on the periphery of 
the tumor and in healthy tissues adjacent to the tumor 
than in patients with CRC of Stage I. It was also found 
that radiation therapy as a pre-operative preparation 
contributed to an increase in the number of NET in 
the center of the tumor in patients with Stage I rectal 
cancer.
Conclusion
As follows from the data obtained, we revealed 
an increase in NET in the center and periphery of CRC, 
and an increase in their number after pre-operative 
radiation therapy was shown. Thus, it is of interest to 
evaluate the ability of neutrophils to form extracellular 
traps in case of socially significant diseases. The next 
stage of our study will be devoted to study the NET 
structural features and their interaction with other 
effector cells and tumor cells.
Data availability
The quantitative data used to support 
the findings of this study are available from the 
corresponding author on request.
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